The Susceptibility Of Dipg Cells To Rg7388 Is Tp53 Dependent A The P53
The susceptibility of DIPG cells to RG7388 is TP53-dependent. A The p53 ...
The susceptibility of DIPG cells to RG7388 is TP53-dependent. A The p53 ...
The identification of a novel TP53 cancer susceptibility mutation ...
RG7388 upregulates mRNA and protein expression of the p53 pathway. (a ...
Antiproliferative activity of RG7388 (A) and activation of the p53 (B ...
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53 ...
Effects of RG7388 as a single agent on activation of the downstream ...
Effects of RG7388 as a single agent on activation of the downstream ...
Advertisement Space (300x250)
ATSP-7041 reactivates the p53 pathway to induce cell death in TP53 ...
The mitochondrial translocation of p53 and p53-induced production of ...
The sensitivity to MDM2 antagonists RG7388 in ALL cell lines and ...
RG7388 was able to reach the brainstem and exert therapeutic efficacy ...
GSK2830371 combination with RG7388 enhanced the inhibition of colony ...
The MDM2 small-molecule inhibitor RG7388 leads to potent tumor ...
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in ...
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging ...
The cell proliferation inhibition IC 50 of XR-4 and RG7388 in different ...
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging ...
Advertisement Space (336x280)
Combination of RG7388 with rucaparib affects the cell cycle ...
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in ...
Identification of a novel TP53 cancer susceptibility mutation through ...
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell ...
The Role of p53 Signaling in Colorectal Cancer
P53 pathway was up-regulated after RG7388 treatment. A Hierarchical ...
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53 ...
RG7388 leads to a significant dose-dependent increase in apoptosis in ...
Effect of RG7388 on p53 wild-type and p53 silenced/null neuroblastoma ...
RG7388 inhibits the HIF-1α/VEGF pathway and alters angiogenesis. RG7388 ...
Advertisement Space (336x280)
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53 ...
(PDF) Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53 ...
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53 ...
The sensitivity to MDM2 antagonists, Nutlin-3 and RG7388, and rucaparib ...
Preclinical efficacy and synergistic potential of the MDM2p53 ...
RG7388 activates p53 pathway and its downstream targets in vivo. A ...